Bank of America
ALBO

Bank of America’s Albireo Pharma Inc ALBO Stock Holding History

Bank of America’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,342
Closed -$267K – 8584
2022
Q4 		$267K Buy
12,342
+6,108
+98% +$129K ﹤0.01% 5762
2022
Q3 		$121K Sell
6,234
-69,031
-92% -$1.43M ﹤0.01% 6252
2022
Q2 		$1.5M Buy
75,265
+26,421
+54% +$697K ﹤0.01% 4552
2022
Q1 		$1.46M Sell
48,844
-17,442
-26% -$511K ﹤0.01% 4884
2021
Q4 		$1.54M Buy
66,286
+52,469
+380% +$1.39M ﹤0.01% 4818
2021
Q3 		$431K Buy
13,817
+2,948
+27% +$91.2K ﹤0.01% 5769
2021
Q2 		$382K Sell
10,869
-13,142
-55% -$427K ﹤0.01% 5634
2021
Q1 		$846K Buy
24,011
+15,682
+188% +$579K ﹤0.01% 4990
2020
Q4 		$313K Sell
8,329
-1,072
-11% -$39K ﹤0.01% 5310
2020
Q3 		$314K Buy
9,401
+473
+5% +$13.8K ﹤0.01% 5027
2020
Q2 		$237K Sell
8,928
-5,020
-36% -$118K ﹤0.01% 5123
2020
Q1 		$228K Buy
13,948
+10,108
+263% +$222K ﹤0.01% 5011
2019
Q4 		$98K Sell
3,840
-664
-15% -$13.3K ﹤0.01% 6010
2019
Q3 		$90K Buy
4,504
+247
+6% +$6.39K ﹤0.01% 6098
2019
Q2 		$138K Buy
4,257
+1,404
+49% +$47K ﹤0.01% 5828
2019
Q1 		$91K Sell
2,853
-3,616
-56% -$97.3K ﹤0.01% 5934
2018
Q4 		$159K Buy
6,469
+3,020
+88% +$79.8K ﹤0.01% 5666
2018
Q3 		$114K Buy
3,449
+1,901
+123% +$62.2K ﹤0.01% 5810
2018
Q2 		$54K Buy
1,548
+65
+4% +$2.1K ﹤0.01% 6107
2018
Q1 		$48K Buy
1,483
+1,479
+36,975% +$49.8K ﹤0.01% 6062
2017
Q4 		$0 Sell
4
-44
-92% -$1.12K ﹤0.01% 7340
2017
Q3 		$1K Sell
48
-89
-65% -$2.12K ﹤0.01% 6965
2017
Q2 		$3K Buy
+137
New +$2.81K ﹤0.01% 6700
2017
Q1 		– Sell
-200
Closed -$3K – 7329
2016
Q4 		$3K Buy
200
+157
+365% +$3.26K ﹤0.01% 6801
2016
Q3 		$0 Buy
43
+18
+72% +$212 ﹤0.01% 7442
2016
Q2 		$0 Hold
25
– – ﹤0.01% 7478
2016
Q1 		$0 Hold
25
– – ﹤0.01% 7428
2015
Q4 		$0 Hold
25
– – ﹤0.01% 7532
2015
Q3 		$0 Hold
25
– – ﹤0.01% 7485
2015
Q2 		$1K Hold
25
– – ﹤0.01% 7155
2015
Q1 		$1K Sell
25
-1
-4% -$42 ﹤0.01% 6888
2014
Q4 		$1K Buy
26
+1
+4% +$44 ﹤0.01% 7580
2014
Q3 		$1K Sell
25
-5
-17% -$287 ﹤0.01% 7908
2014
Q2 		$2K Buy
30
+1
+3% +$70 ﹤0.01% 7849
2014
Q1 		$2K Buy
29
+3
+12% +$273 ﹤0.01% 7551
2013
Q4 		$2K Sell
26
-21
-45% -$1.54K ﹤0.01% 7658
2013
Q3 		$4K Buy
47
+22
+88% +$2.86K ﹤0.01% 7474
2013
Q2 		$3K Buy
+25
New +$2.6K ﹤0.01% 7467

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of America's ALBO Position: Q1 2023 in Review

Bank of America sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 12,342 shares — an estimated $267K sold.

Bank of America first reported a position in ALBO in Q2 2013 and held it in 38 quarters. The position peaked at $1.54M in Q4 2021. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • Bank of America reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • Bank of America sold 12,342 Albireo Pharma Inc shares in Q1 2023, an estimated $267K.
  • Bank of America first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 38 quarters.
  • Bank of America's Albireo Pharma Inc position peaked at $1.54M in Q4 2021.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.